News
A novel study has unveiled a technique that enhances stem cell therapy for neurodegenerative diseases by combining magnetic ...
Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 5.08%, which has investors questioning if this is right time ...
Researchers use biocompatible polydopamine nanoparticles and near-infrared light to remotely trigger activity in neuron and ...
Fingrut, MD, assistant professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center. Stem cell donations can be done in different ways ...
"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...
Researchers have identified a key enzyme driving forms of Parkinson's disease, and have shown how blocking it restores normal function in animal and cell models, offering a promising new drug target ...
The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...
Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the ...
Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...
Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...
Mounting evidence suggests there might be two separate types of the world’s fastest-growing neurological condition. Can this ...
AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results